JD Health International Inc.
JD Health International Inc. (6618.HK) Stock Competitors & Peer Comparison
See (6618.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 6618.HK | HK$52.30 | +2.65% | 167.4B | 36.32 | HK$1.44 | N/A |
| 6078.HK | HK$16.64 | -1.71% | 10.1B | 16.16 | HK$1.03 | N/A |
| 1951.HK | HK$3.22 | +0.00% | 8.7B | 29.27 | HK$0.11 | N/A |
| 2273.HK | HK$33.94 | -0.76% | 7.9B | 25.52 | HK$1.33 | +1.59% |
| 2373.HK | HK$27.16 | +2.57% | 6.4B | 25.15 | HK$1.08 | N/A |
| 1515.HK | HK$3.68 | -0.54% | 4.7B | 7.51 | HK$0.49 | +3.90% |
| 2453.HK | HK$5.76 | +0.17% | 4.4B | -8.60 | -HK$0.67 | N/A |
| 3309.HK | HK$1.79 | +0.00% | 2.2B | -16.27 | -HK$0.11 | +1.12% |
| 2219.HK | HK$3.05 | +2.69% | 2.1B | 10.17 | HK$0.30 | +8.20% |
| 3886.HK | HK$0.28 | +0.00% | 1.9B | -9.33 | -HK$0.03 | +0.43% |
Stock Comparison
6618.HK vs 6078.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 6078.HK has a market cap of 10.1B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 6078.HK trades at HK$16.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 6078.HK's P/E ratio is 16.16. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 6078.HK's ROE of +0.09%. Regarding short-term risk, 6618.HK is less volatile compared to 6078.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6618.HK.Check 6078.HK's competition here
6618.HK vs 1951.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 1951.HK has a market cap of 8.7B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 1951.HK trades at HK$3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 1951.HK's P/E ratio is 29.27. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 1951.HK's ROE of +0.03%. Regarding short-term risk, 6618.HK is less volatile compared to 1951.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6618.HK.Check 1951.HK's competition here
6618.HK vs 2273.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 2273.HK has a market cap of 7.9B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 2273.HK trades at HK$33.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 2273.HK's P/E ratio is 25.52. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 2273.HK's ROE of +0.13%. Regarding short-term risk, 6618.HK is more volatile compared to 2273.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 2273.HK's competition here
6618.HK vs 2373.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 2373.HK has a market cap of 6.4B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 2373.HK trades at HK$27.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 2373.HK's P/E ratio is 25.15. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 2373.HK's ROE of +0.26%. Regarding short-term risk, 6618.HK is less volatile compared to 2373.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6618.HK.Check 2373.HK's competition here
6618.HK vs 1515.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 1515.HK has a market cap of 4.7B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 1515.HK trades at HK$3.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 1515.HK's P/E ratio is 7.51. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 1515.HK's ROE of +0.09%. Regarding short-term risk, 6618.HK is more volatile compared to 1515.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 1515.HK's competition here
6618.HK vs 2453.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 2453.HK has a market cap of 4.4B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 2453.HK trades at HK$5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 2453.HK's P/E ratio is -8.60. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 2453.HK's ROE of -0.25%. Regarding short-term risk, 6618.HK is more volatile compared to 2453.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 2453.HK's competition here
6618.HK vs 3309.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 3309.HK has a market cap of 2.2B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 3309.HK trades at HK$1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 3309.HK's P/E ratio is -16.27. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 3309.HK's ROE of -0.08%. Regarding short-term risk, 6618.HK is more volatile compared to 3309.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 3309.HK's competition here
6618.HK vs 2219.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 2219.HK has a market cap of 2.1B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 2219.HK trades at HK$3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 2219.HK's P/E ratio is 10.17. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 2219.HK's ROE of +0.08%. Regarding short-term risk, 6618.HK is more volatile compared to 2219.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 2219.HK's competition here
6618.HK vs 3886.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 3886.HK has a market cap of 1.9B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 3886.HK trades at HK$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 3886.HK's P/E ratio is -9.33. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 3886.HK's ROE of -0.07%. Regarding short-term risk, 6618.HK is less volatile compared to 3886.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6618.HK.Check 3886.HK's competition here
6618.HK vs 0708.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 0708.HK has a market cap of 1.8B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 0708.HK trades at HK$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 0708.HK's P/E ratio is -0.07. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 0708.HK's ROE of +0.21%. Regarding short-term risk, 6618.HK is less volatile compared to 0708.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6618.HK.Check 0708.HK's competition here
6618.HK vs 1526.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 1526.HK has a market cap of 1.7B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 1526.HK trades at HK$1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 1526.HK's P/E ratio is 5.14. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 1526.HK's ROE of +0.23%. Regarding short-term risk, 6618.HK is more volatile compared to 1526.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 1526.HK's competition here
6618.HK vs 9960.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 9960.HK has a market cap of 1.6B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 9960.HK trades at HK$1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 9960.HK's P/E ratio is -26.33. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 9960.HK's ROE of -0.02%. Regarding short-term risk, 6618.HK is more volatile compared to 9960.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 9960.HK's competition here
6618.HK vs 6639.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 6639.HK has a market cap of 1.5B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 6639.HK trades at HK$2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 6639.HK's P/E ratio is 52.20. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 6639.HK's ROE of +0.01%. Regarding short-term risk, 6618.HK is less volatile compared to 6639.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6618.HK.Check 6639.HK's competition here
6618.HK vs 1846.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 1846.HK has a market cap of 1B. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 1846.HK trades at HK$3.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 1846.HK's P/E ratio is 13.08. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 1846.HK's ROE of +0.07%. Regarding short-term risk, 6618.HK is less volatile compared to 1846.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6618.HK.Check 1846.HK's competition here
6618.HK vs 9906.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 9906.HK has a market cap of 906M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 9906.HK trades at HK$1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 9906.HK's P/E ratio is 21.57. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 9906.HK's ROE of +0.05%. Regarding short-term risk, 6618.HK is more volatile compared to 9906.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 9906.HK's competition here
6618.HK vs 0383.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 0383.HK has a market cap of 897.8M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 0383.HK trades at HK$0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 0383.HK's P/E ratio is 27.67. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 0383.HK's ROE of +0.02%. Regarding short-term risk, 6618.HK is more volatile compared to 0383.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 0383.HK's competition here
6618.HK vs 1989.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 1989.HK has a market cap of 812.6M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 1989.HK trades at HK$0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 1989.HK's P/E ratio is -22.50. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 1989.HK's ROE of -0.16%. Regarding short-term risk, 6618.HK is more volatile compared to 1989.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 1989.HK's competition here
6618.HK vs 3869.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 3869.HK has a market cap of 704.3M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 3869.HK trades at HK$5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 3869.HK's P/E ratio is -16.77. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 3869.HK's ROE of -0.11%. Regarding short-term risk, 6618.HK is less volatile compared to 3869.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6618.HK.Check 3869.HK's competition here
6618.HK vs 3689.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 3689.HK has a market cap of 642M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 3689.HK trades at HK$1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 3689.HK's P/E ratio is 38.40. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 3689.HK's ROE of +0.01%. Regarding short-term risk, 6618.HK is less volatile compared to 3689.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6618.HK.Check 3689.HK's competition here
6618.HK vs 2120.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 2120.HK has a market cap of 641.8M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 2120.HK trades at HK$9.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 2120.HK's P/E ratio is 9.41. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 2120.HK's ROE of +0.05%. Regarding short-term risk, 6618.HK is more volatile compared to 2120.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 2120.HK's competition here
6618.HK vs 2389.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 2389.HK has a market cap of 569.5M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 2389.HK trades at HK$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 2389.HK's P/E ratio is -4.70. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 2389.HK's ROE of -0.07%. Regarding short-term risk, 6618.HK is more volatile compared to 2389.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 2389.HK's competition here
6618.HK vs 2189.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 2189.HK has a market cap of 450M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 2189.HK trades at HK$0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 2189.HK's P/E ratio is 22.50. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 2189.HK's ROE of +0.16%. Regarding short-term risk, 6618.HK is more volatile compared to 2189.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 2189.HK's competition here
6618.HK vs 1518.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 1518.HK has a market cap of 409.9M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 1518.HK trades at HK$0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 1518.HK's P/E ratio is 7.64. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 1518.HK's ROE of +0.09%. Regarding short-term risk, 6618.HK is more volatile compared to 1518.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 1518.HK's competition here
6618.HK vs 0722.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 0722.HK has a market cap of 383.8M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 0722.HK trades at HK$0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 0722.HK's P/E ratio is 9.60. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 0722.HK's ROE of +0.06%. Regarding short-term risk, 6618.HK is more volatile compared to 0722.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 0722.HK's competition here
6618.HK vs 1419.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 1419.HK has a market cap of 353M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 1419.HK trades at HK$0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 1419.HK's P/E ratio is 18.60. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 1419.HK's ROE of +0.03%. Regarding short-term risk, 6618.HK is less volatile compared to 1419.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6618.HK.Check 1419.HK's competition here
6618.HK vs 8405.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 8405.HK has a market cap of 276M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 8405.HK trades at HK$0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 8405.HK's P/E ratio is 9.86. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 8405.HK's ROE of +0.14%. Regarding short-term risk, 6618.HK is more volatile compared to 8405.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 8405.HK's competition here
6618.HK vs 0286.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 0286.HK has a market cap of 251.6M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 0286.HK trades at HK$1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 0286.HK's P/E ratio is -0.86. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 0286.HK's ROE of -0.22%. Regarding short-term risk, 6618.HK is more volatile compared to 0286.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 0286.HK's competition here
6618.HK vs 2293.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 2293.HK has a market cap of 221.4M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 2293.HK trades at HK$0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 2293.HK's P/E ratio is 9.17. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 2293.HK's ROE of +0.11%. Regarding short-term risk, 6618.HK is more volatile compared to 2293.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 2293.HK's competition here
6618.HK vs 8143.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 8143.HK has a market cap of 136.4M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 8143.HK trades at HK$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 8143.HK's P/E ratio is -12.10. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 8143.HK's ROE of -0.29%. Regarding short-term risk, 6618.HK is less volatile compared to 8143.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6618.HK.Check 8143.HK's competition here
6618.HK vs 8357.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 8357.HK has a market cap of 101.1M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 8357.HK trades at HK$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 8357.HK's P/E ratio is -16.20. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 8357.HK's ROE of -0.01%. Regarding short-term risk, 6618.HK is more volatile compared to 8357.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 8357.HK's competition here
6618.HK vs 8307.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 8307.HK has a market cap of 84.9M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 8307.HK trades at HK$0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 8307.HK's P/E ratio is -21.40. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 8307.HK's ROE of -0.47%. Regarding short-term risk, 6618.HK is more volatile compared to 8307.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 8307.HK's competition here
6618.HK vs 2135.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 2135.HK has a market cap of 70.2M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 2135.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 2135.HK's P/E ratio is -1.05. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 2135.HK's ROE of +0.00%. Regarding short-term risk, 6618.HK is more volatile compared to 2135.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 2135.HK's competition here
6618.HK vs 8161.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 8161.HK has a market cap of 18.9M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 8161.HK trades at HK$0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 8161.HK's P/E ratio is 2.39. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 8161.HK's ROE of -2.14%. Regarding short-term risk, 6618.HK is more volatile compared to 8161.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 8161.HK's competition here
6618.HK vs 8437.HK Comparison August 2025
6618.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6618.HK stands at 167.4B. In comparison, 8437.HK has a market cap of 9.7M. Regarding current trading prices, 6618.HK is priced at HK$52.30, while 8437.HK trades at HK$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6618.HK currently has a P/E ratio of 36.32, whereas 8437.HK's P/E ratio is -0.45. In terms of profitability, 6618.HK's ROE is +0.08%, compared to 8437.HK's ROE of +0.20%. Regarding short-term risk, 6618.HK is more volatile compared to 8437.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6618.HK.Check 8437.HK's competition here